Α Case of Severe Thyroid Eye Disease Treated with Tocilizumab

Mehmet, Aysel; Panagiotopoulou, Eirini Kanella; Konstantinidis, Aristeidis; Papagoras, Charalampos; Skendros, Panagiotis; Dardabounis, Doukas; Mikropoulou, Athanasia Maria; Labiris, Georgios

doi:10.14712/18059694.2021.12

Acta Medica > Archive > 2021, Vol. 64 > Issue 1 > Α Case of Severe Thyroid Eye Disease…

Acta Med. 2021, 64: 64-69

https://doi.org/10.14712/18059694.2021.12

Α Case of Severe Thyroid Eye Disease Treated with Tocilizumab

Aysel Mehmet^a, Eirini Kanella Panagiotopoulou^a, Aristeidis Konstantinidis^a, Charalampos Papagoras^b, Panagiotis Skendros^b, Doukas Dardabounis^a, Athanasia Maria Mikropoulou^a, Georgios Labiris^a

^aUniversity Eye Clinic, University Hospital of Alexandroupolis, Greece
^bUniversity Department of Internal Medicine, University Hospital of Alexandroupolis, Greece

Received November 10, 2020
Accepted January 18, 2021

This is a case report describing a patient with severe thyroid eye disease complicated with dysthyroid optic neuropathy that was unresponsive to intravenous steroids and orbital radiotherapy but responded well to intravenous tocilizumab.